Literature DB >> 23480827

Variable contributions of basic residues forming an APC exosite in the binding and inactivation of factor VIIIa.

Masahiro Takeyama1, Jennifer M Wintermute, Chandrashekhara Manithody, Alireza R Rezaie, Philip J Fay.   

Abstract

Basic residues contained in the 39-, 60-, and 70-80-loops of activated protein C (APC) comprise an exosite that contributes to the binding and subsequent proteolytic inactivation of factor (F) VIIIa. Surface plasmon resonance (SPR) showed that WT APC bound to FVIII light chain (LC) and the FVIIIa A1/A3C1C2 dimer with equivalent affinity (Kd = 525 and 546 nM, respectively). These affinity values may reflect binding interactions to the acidic residue-rich a1 and a3 segments adjacent to A1 domain in the A1/A3C1C2 and A3 domain in LC, respectively. Results from SPR, using a panel of APC exosite variants where basic residues were mutated, in binding to immobilized FVIIIa A1/A3C1C2 or LC indicated ~4-10-fold increases in the Kd values relative to WT for several of the variants including Lys39Ala, Lys37-Lys38-Lys39/Pro-Gln-Glu, and Arg67Ala. On the other hand, a number of APC variants including Lys38Ala, Lys62Ala, and Lys78Ala showed little if any change in binding affinity to the FVIII substrates. FXa generation assays and Western blotting, used to monitor rates of FVIIIa inactivation and proteolysis at the primary cleavage site in the cofactor (Arg(336)), respectively, showed marked rate reductions relative to WT for the Lys39Ala, Lys37-Lys38-Lys39/Pro-Gln-Glu, Arg67Ala, and Arg74Ala variants. Furthermore, kinetic analysis monitoring FVIIIa inactivation by APC variants at varying FVIIIa substrate concentration showed ~2.6-4.4-fold increases in Km values relative to WT. These results show a variable contribution of basic residues comprising the APC exosite, with significant contributions from Lys39, Arg67, and Arg74 to forming a FVIIIa-interactive site.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23480827      PMCID: PMC3645000          DOI: 10.1021/bi301632g

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  38 in total

1.  Molecular characterization of an extended binding site for coagulation factor Va in the positive exosite of activated protein C.

Authors:  Andrew J Gale; Alexander Tsavaler; John H Griffin
Journal:  J Biol Chem       Date:  2002-06-12       Impact factor: 5.157

2.  Identification of a factor Xa-interactive site within residues 337-372 of the factor VIII heavy chain.

Authors:  Keiji Nogami; Kirsty A Lapan; Qian Zhou; Hironao Wakabayashi; Philip J Fay
Journal:  J Biol Chem       Date:  2004-02-04       Impact factor: 5.157

Review 3.  Activation of factor VIII and mechanisms of cofactor action.

Authors:  Philip J Fay
Journal:  Blood Rev       Date:  2004-03       Impact factor: 8.250

4.  Isolation and characterization of human factor VIII: molecular forms in commercial factor VIII concentrate, cryoprecipitate, and plasma.

Authors:  L O Andersson; N Forsman; K Huang; K Larsen; A Lundin; B Pavlu; H Sandberg; K Sewerin; J Smart
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

5.  Proteolytic processing of human factor VIII. Correlation of specific cleavages by thrombin, factor Xa, and activated protein C with activation and inactivation of factor VIII coagulant activity.

Authors:  D Eaton; H Rodriguez; G A Vehar
Journal:  Biochemistry       Date:  1986-01-28       Impact factor: 3.162

6.  The size of human factor VIII heterodimers and the effects produced by thrombin.

Authors:  P J Fay; M T Anderson; S I Chavin; V J Marder
Journal:  Biochim Biophys Acta       Date:  1986-06-23

7.  Structure of human factor VIII.

Authors:  G A Vehar; B Keyt; D Eaton; H Rodriguez; D P O'Brien; F Rotblat; H Oppermann; R Keck; W I Wood; R N Harkins; E G Tuddenham; R M Lawn; D J Capon
Journal:  Nature       Date:  1984 Nov 22-28       Impact factor: 49.962

8.  Construction and characterization of an active factor VIII variant lacking the central one-third of the molecule.

Authors:  D L Eaton; W I Wood; D Eaton; P E Hass; P Hollingshead; K Wion; J Mather; R M Lawn; G A Vehar; C Gorman
Journal:  Biochemistry       Date:  1986-12-30       Impact factor: 3.162

9.  Contribution of basic residues of the 70-80-loop to heparin binding and anticoagulant function of activated protein C.

Authors:  Likui Yang; Chandrashekhara Manithody; Alireza R Rezaie
Journal:  Biochemistry       Date:  2002-05-14       Impact factor: 3.162

10.  Phospholipid vesicle formation and transmembrane protein incorporation using octyl glucoside.

Authors:  L T Mimms; G Zampighi; Y Nozaki; C Tanford; J A Reynolds
Journal:  Biochemistry       Date:  1981-02-17       Impact factor: 3.162

View more
  1 in total

1.  Unreported intrinsic disorder in proteins: Building connections to the literature on IDPs.

Authors:  Vladimir N Uversky
Journal:  Intrinsically Disord Proteins       Date:  2014-12-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.